Shanghai, China, Immediate Release - April 19, 2018, Waters held the "Biopharmaceutical Latest Analysis Technology and Solution Launch Conference" at BioCon China 2018, officially releasing the ACQUITY Arc Bio System to the Chinese market. Shanghai Jiao Tong University Medicine Dean of the Faculty, Dr. Zhu Jianwei, Distinguished Specialist Dr. Zhu Jianwei of the Central Organization Department, Ms. Huang Jing, Marketing Director of Waters China, Dr. Ni Qihui, Senior Product Manager of Waters, and Dr. Scott J. Berger, Senior Manager of Waters Biopharmaceutical Unveiling of new products.
(Left to right) Ms. Huang Jing, Waters China Marketing Director, Dr. Zhu Jianwei, Dean, School of Pharmacy, Shanghai Jiao Tong University, Dr. Scott J. Berger, Senior Waters Biopharmaceutical Manager, and Dr. Ni Qihui, Waters Chief Product Manager Product launch
Before the unveiling ceremony, Ms. Huang Jing, Marketing Director of Waters China stated in his welcome speech: 'As an industry leader in analytical technologies, Waters has always provided the goal of meeting the different needs of the laboratory in various stages, providing customers with business objectives. Strong support. The release of the ACQUITY Arc Bio System is another embodiment of this commitment. Waters will continue to collaborate and communicate with customers and continue to promote efficient, innovative biomedical solutions. Users and partners have greater success in biopharmaceuticals. '
Waters China Marketing Director Ms. Huang Jing
Subsequently, Dr. Zhu Jianwei, Dean of the Pharmaceutical Institute of Shanghai Jiaotong University and a distinguished expert of the “One Thousand Talents Program” of the Central Organization Department shared a wonderful report on the “Trends of Quality Control Analysis Technology from the Experience of Chinese Biopharmaceuticals,” from the research and development of biopharmaceuticals at home and abroad. The application and approval status is the starting point, emphasizing the important role of analytical techniques in the key links such as IND declaration, manufacturing, quality control and product release for the biological macromolecules with higher complexity.
Dean of School of Pharmacy, Shanghai Jiao Tong University, Dr. Zhu Jianwei, Special Expert of the '1000 Personnel Program' of the Central Organization Department
ACQUITY Arc Bio is a new tool to meet the challenges of conventional biological separation. It was first released worldwide in February 2018 and is a universal quaternary LC system. It is made from non-ferrous bio-inert materials and can be effectively converted and improved. Any bioseparation method developed on an LC platform. The system is based on the proven ACQUITY Arc system and uses the innovative Arc Multi-flow path technology to provide the necessary versatility and stability to assist users without compromising the integrity of the method. Efficient method conversion, adjustment or optimization.
Waters ACQUITY Arc Bio System
At the Chinese premiere meeting, Dr. Ni Qihui, Senior Product Manager of Waters headquarters, introduced in detail the main features of the system and its application in conventional bioseparation. She said: 'The biomolecules of the ACQUITY Arc Bio system Extremely low residual and extremely high recovery, ideal for LC methods running reverse phase, ion exchange, size exclusion and hydrophobicity. Benefit from unique Arc Multi-flow path technology - by modifying the system's delay volume simulation The delay volume of the instrument used in the development of the method, which is compatible with HPLC and UHPLC methods in a 'plug-and-play' manner, greatly shortens the time required for the redevelopment method.
Waters Chief Product Manager Dr. Ni Qihui
Subsequently, Dr. Scott J. Berger, Senior Manager of Waters Biopharmaceuticals, gave a keynote report titled 'Strategies for Full Chain Analysis of Protein Drugs', sharing the Waters analysis product line and the ACQUITY QDa Detector for different analytical needs. Application to help biopharmaceutical laboratories solve various analytical challenges and comply with regulations.
Waters BioPharma Senior Manager Scott J. Berger
Mr. Zhang Yifan, Head of Biotechnology Drug Development Department of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co., Ltd., made a wonderful presentation entitled 'The Flexible Application of LC-MS Technology in the Quality Control and Control of Monoclonal Antibodies and ADC', from Monoclonal Antibody to Antibody Pair. In conjunction with pharmaceuticals, LC-MS technology is a very effective means of quality analysis work that can help streamline processes, improve data quality and accuracy of results.
Zhang Yifan, Head of Biotech Drug Development Department, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co., Ltd.
Lastly, Ms. Zhang Yushu, Senior Compliance Adviser, Waters Informatics Department, also shared a biopharmaceutical analysis laboratory management solution that meets the data integrity requirements, highlighting Waters Labs Information Platform, which can help users complete CTD reporting, efficient management of Gxp laboratory systems.
Ms. Zhang Yushu, Senior Compliance Adviser, Waters Informatics Department